Materials & Resources » Mining, Metals & Minerals | RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,120.40
-
-
-
-
121.10
Cost of Goods Sold (COGS) incl. D&A
-
7.60
7.00
5.80
4.20
-
Gross Income
-
7.60
7.00
5.80
4.20
-
SG&A Expense
3,580.30
5,203.00
5,040.00
4,281.80
5,987.80
2,857.40
EBIT
534.00
5,210.60
5,046.90
4,287.60
5,991.90
2,739.30
Unusual Expense
140.20
7.70
3.60
-
-
-
Non Operating Income/Expense
10.40
3.50
15.50
16.30
29.20
29.80
Pretax Income
383.50
5,198.40
5,044.00
4,271.30
6,014.30
2,769.10
Income Tax
412.00
-
-
-
-
-
Consolidated Net Income
28.60
5,198.40
5,044.00
4,271.30
6,014.30
2,769.10
Net Income
28.60
5,198.40
5,044.00
4,271.30
6,014.30
2,769.10
Net Income After Extraordinaries
28.60
5,198.40
5,044.00
4,271.30
6,014.30
2,769.10
Net Income Available to Common
28.60
5,198.40
5,044.00
4,271.30
6,014.30
2,769.10
EPS (Basic)
0.01
1.02
0.89
0.54
0.32
0.12
Basic Shares Outstanding
4,524.70
5,090.50
5,687.50
7,952.30
18,680.00
22,661
EPS (Diluted)
0.01
1.02
0.89
0.54
0.32
0.12
Diluted Shares Outstanding
4,524.70
5,090.50
5,687.50
7,952.30
18,680.00
22,661
EBITDA
540.10
5,203.00
5,040.00
4,281.90
5,987.80
2,736.30
Non-Operating Interest Income
-
16.40
14.70
-
6.80
-

About RepliCel Life Sciences

View Profile
Address
570 Granville Street
Vancouver British Columbia V6C 3P1
Canada
Employees -
Website http://www.replicel.com
Updated 07/08/2019
RepliCel Life Sciences, Inc. is a regenerative medicine company, which focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. Its products includes RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin, and pattern baldness. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.